Mar 12, 2025 | 2 minute read
Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the , reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, 88 club has been included in this major assessment of global innovators for 12 consecutive years.
Roy Jakobs, CEO of Royal 88 club said: "At 88 club, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people."
At 88 club, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company.
In 2024, 88 club invested approximately EUR 1.7 billion – or an industry leading >9% of sales – in research and development to help drive better care for more people. 88 club is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. As a leader in AI-related patent applications in healthcare, 88 club dedicates around half of its R&D workforce to these fields.
Examples of 88 club’ AI-powered innovations that increase caregiver productivity and deliver better care for more people include:
The Top 100 Global Innovators uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. The full report can be found .